SAM
AGN

Silvercrest Asset Management’s Allergan Inc AGN Stock Holding History

Silvercrest Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-73,294
Closed -$15.6M – 507
2014
Q4 		$15.6M Sell
73,294
-34,294
-32% -$6.82M 0.23% 121
2014
Q3 		$19.2M Sell
107,588
-17,920
-14% -$2.98M 0.3% 107
2014
Q2 		$21.2M Sell
125,508
-16,385
-12% -$2.55M 0.32% 103
2014
Q1 		$17.6M Sell
141,893
-50
-0% -$6.09K 0.28% 115
2013
Q4 		$15.8M Hold
141,943
– – 0.26% 113
2013
Q3 		$12.8M Sell
141,943
-39
-0% -$3.5K 0.25% 116
2013
Q2 		$12M Buy
+141,982
New +$14.7M 0.25% 110

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Silvercrest Asset Management's AGN Position: Q1 2015 in Review

Silvercrest Asset Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 73,294 shares — an estimated $15.6M sold.

Silvercrest Asset Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $21.2M in Q2 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Silvercrest Asset Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Silvercrest Asset Management sold 73,294 Allergan Inc shares in Q1 2015, an estimated $15.6M.
  • Silvercrest Asset Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Silvercrest Asset Management's Allergan Inc position peaked at $21.2M in Q2 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Silvercrest Asset Management's 13F filing for Q1 2015, filed 15 May 2015.